GGrantIndex
Sort

130,381 grants matching hiv

Pathogenesis and Treatment of HIV Infection

$1,498,149
Henry C Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Einstein-Rockefeller-CUNY Center for AIDS Research

$1,498,120
Harris Goldstein · Albert Einstein College Of Medicine, Inc · P30 · FY2017 · AI

Large Scale T Cell Epitope Discovery: Local and Systemic T cell Response to Herpes Simplex Virus

$1,498,077
Tim Myer · University Of Washington · N01 · FY2021 · AI

MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)

$1,497,671
Jeanette Coffin · Midwest Research Institute · N01 · FY2021 · AI

Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois

$1,497,463
Lawrence J Ouellet · University Of Illinois At Chicago · R01 · FY2011 · DA

Immunological Strategies to Modulate SIV Rebound Following ART Interruption

$1,497,359
Michael R Betts · University Of Pennsylvania · P01 · FY2021 · AI

COLUMBIA/ROCKEFELLER CENTER FOR AIDS RESEARCH

$1,496,652
Columbia University Health Sciences · P30 · FY2001 · AI

HIV Disease Outcomes in Drug Users in Clinical Practice

$1,496,559
Richard Douglas Moore · Johns Hopkins University · U01 · FY2017 · DA

HIV Disease Outcomes in Drug Users in Clinical Practice

$1,496,559
Richard Douglas Moore · Johns Hopkins University · U01 · FY2019 · DA

Targeted Neuroprotection for HIV-1 Associated Dementia

$1,496,456
University Of Rochester · P01 · FY2003 · MH

HIV and Tumor Molecular Characterization Project (HTMCP)

$1,496,274
Maureen Dyer · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA

Alcohol Associated Outcomes Among HIV+/-Aging Veterans

$1,496,218
University Of Pittsburgh At Pittsburgh · R01 · FY2001 · AA

Tfh and B cells in HIV/SIV pathogenesis and vaccination

$1,496,217
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG

$1,496,173
University Of Miami School Of Medicine · U01 · FY2005 · AI

NINDS Quantitative MRI Core Facility

$1,496,165
Govind Bhagavatheeshwaran · National Institute Of Neurological Disorders And Stroke · ZIC · FY2022 · NS

Lambda Genetic Networks and Lambda Red-Mediated Recombination

$1,495,905
Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Viral dynamics of rebound and control following early treatment of HIV/SIV

$1,495,833
James Burton Whitney · Beth Israel Deaconess Medical Center · P01 · FY2017 · AI

Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois

$1,495,783
Lawrence J Ouellet · University Of Illinois At Chicago · R01 · FY2012 · DA

Scientific Administrative Core (SAC)

$1,495,746
George R Seage · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2024 · HD

CLINICAL TRIALS OF ANTIFUNGAL THERAPIES

$1,495,655
University Of Alabama At Birmingham · N01 · FY2000 · AI

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$1,495,558
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Stellenbosch University Clinical Trials Unit

$1,495,502
Anneke Catharina Hesseling · Stellenbosch University · UM1 · FY2025 · AI

CLINICAL PHARMACOLOGY QUALITY ASSURANCE

$1,495,464
Eugene Morse · State University Of New York At Buffalo · N01 · FY2019 · AI

Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies

$1,495,269
Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2013 · AI

GABONESE DEFENSE AND SECURITY FORCES (FDSG) PARTNERSHIP FOR SUSTAINABLE HIV EPIDEMIC CONTROL

$1,495,250
Medical Care Development Inc · · FY2025 · Defense Health Agency